Brief: Glaxosmithkline Pharma Q2 Consol Profit 2.57 Billion Rupees
06/11/2025 10:58
Nov 6 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd GLAX.NS: GLAXOSMITHKLINE PHARMA Q2 CONSOL PROFIT 2.57 BILLION RUPEES GLAXOSMITHKLINE PHARMA Q2 CONSOL REVENUE FROM OPERATIONS 9.8 BILLION RUPEES Source text: [ID:] Further company coverage: GLAX.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees